Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [electronic resource]
Producer: 20161213Description: e156-78 p. digitalISSN:- 1524-4539
- Advisory Committees -- standards
- American Heart Association
- Aspirin -- administration & dosage
- Cardiology -- methods
- Coronary Artery Disease -- diagnosis
- Drug Administration Schedule
- Drug Therapy, Combination
- Drug-Eluting Stents -- adverse effects
- Hemorrhage -- chemically induced
- Humans
- Platelet Aggregation Inhibitors -- administration & dosage
- Practice Guidelines as Topic -- standards
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Randomized Controlled Trials as Topic -- methods
- Research Report -- standards
- Thrombosis -- etiology
- Time Factors
- United States -- epidemiology
No physical items for this record
Publication Type: Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.